Fusion Pharmaceuticals(FUSN) - 2021 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Securities registered pursuant to Section 12(b) of the Act: | Trading | | | | --- | --- | --- | | Title of each class Name of each exchange on which registered | | Symbol(s) | | Common shares, no par value per share FUSN The Nasdaq Global Select Market | | | | Securities registered pursuant to Section 12(g) of the Act: | | | | Non ...